[Federal Register Volume 91, Number 164 (Wednesday, August 26, 2026)]
[Notices]
[Page 55104]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-17409]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Docket No. HHS-OASH-2026-0232] Temporary Placement of 7-
Hydroxymitragynine Above a Specified Threshold in Schedule I;
Extension of Comment Period
AGENCY: Office of the Assistant Secretary for Health, Department of
Health and Human Services.
ACTION: Notice; request for information; extension of comment period
for the Request for Information and for its information collection
provisions.
-----------------------------------------------------------------------
SUMMARY: The Office of the Assistant Secretary for Health (OASH or we)
is extending the comment period to solicit input and comments on a
Request for Information (RFI) on a proposed threshold for 7-
hydroxymitragynine (7-OH) scheduling under the Controlled Substances
Act that appeared in the Federal Register of July 6, 2026. Public
comments submitted to this docket will be provided by the Secretary for
Health and Human Services for consideration by the Attorney General. We
are taking this action in response to a request for an extension to
allow interested persons additional time to provide comments and input.
DATES: Submit either electronic or written comments, data, or
information by September 10, 2026.
ADDRESSES: Request for Information (RFI) Docket: You may examine the
full RFI docket at regulations.gov under HHS-OASH-2026-0232. To submit
a response, click the ``Comment'' button inside Docket: HHS-OASH-2026-
0232 and follow all instructions.
FOR FURTHER INFORMATION CONTACT: Ruben Hernandez Segarra,
[email protected]
SUPPLEMENTARY INFORMATION:
In the Federal Register of July 6, 2026, we published an RFI
entitled ``Temporary Placement of 7-Hydroxymitragynine Above a
Specified Threshold in Schedule I; Request for Information'' with a
comment period that closed on July 31, 2026. This RFI sought input on
the proposed 7-OH threshold that was listed by the Drug Enforcement
Administration (DEA) that was issued in the Federal Register entitled
``Schedules of Controlled Substance: Temporary Placement of 7-
Hydroxymitragynine Above a Specified Threshold in Schedule I.''
OASH has received a request for an extension of the comment period
on this RFI to allow any interested persons additional time to provide
comments. OASH has considered the request and is granting the extension
of the comment period to allow any interested persons additional
opportunity to provide comments. OASH believes that this extension
allows adequate time for any interested persons to fully consider and
submit comments.
Note that OASH is not soliciting comments on any permanent
scheduling decision, the general safety or utility of kratom-derived
products, or other policy questions outside the scope of the threshold
determination for temporary scheduling. Public comments submitted to
this docket will be provided by the Secretary for Health and Human
Services for consideration by the Attorney General.
Brian Christine
Assistant Secretary for Health, Department of Health and Human
Services.
[FR Doc. 2026-17409 Filed 8-25-26; 8:45 am]
BILLING CODE 4164-01-P